The potential oncogenic role of UBE2S is significantly linked to unfavorable prognosis in ovarian cancer patients, and is responsible for the promotion of ovarian cancer development through the regulation of apoptosis and cell cycle via PI3K/AKT/mTOR signaling. The gene discussed is MTOR; the disease is ovarian carcinoma.